Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Cleft Palate D002972 9 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Contusions D003288 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Coronary Vasospasm D003329 9 associated lipids
Cough D003371 19 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Diseases in Twins D004200 4 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Smith AJ et al. Hypertensive and normal pregnancy: a longitudinal study of blood pressure, distensibility of dorsal hand veins and the ratio of the stable metabolites of thromboxane A2 and prostacyclin in plasma. 1995 Br J Obstet Gynaecol pmid:8534627
Landoni MF and Lees P Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling. 1995 Equine Vet. J. pmid:8536660
Shimizu Y et al. Nafamostat mesilate prevents warm ischemia-reperfusion injury in canine pancreas autotransplantation. 1995 Transplant. Proc. pmid:8539906
Blache D et al. Occurrence and biological effects of cholesteryl sulfate on blood platelets. 1995 Biochim. Biophys. Acta pmid:8541337
Lees P et al. Pharmacodynamics and pharmacokinetics of carprofen in the horse. 1994 Equine Vet. J. pmid:8542839
Daugschies A Oesophagostomum dentatum: population dynamics and synthesis of prostanoids by histotropic stages cultured in vitro. 1995 Exp. Parasitol. pmid:8542999
Kato A et al. Role of thromboxane A2 and prostacyclin in uninephrectomy-induced attenuation of ischemic renal injury. 1995 Kidney Int. pmid:8544417
Morioka K et al. Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass. 1996 J. Thorac. Cardiovasc. Surg. pmid:8551788
Wang TL et al. The evolution of platelet aggregability in patients undergoing catheter ablation for supraventricular tachycardia with radiofrequency energy: the role of antiplatelet therapy. 1995 Pacing Clin Electrophysiol pmid:8552510
Liu W et al. [Effects of selenium and vitamin E on arachidonic acid metabolism in experimental myocardial ischaemia]. 1995 Zhonghua Yu Fang Yi Xue Za Zhi pmid:8556938
Satterwhite JH and Boudinot FD Effects of age on the pharmacodynamics of naproxen in the rat. 1995 Sep-Oct Exp. Gerontol. pmid:8557098
Kawikova I et al. Bradykinin-induced release of thromboxane B2 into bronchoalveolar lavage fluid of guinea pigs: relationship to airflow obstruction. 1995 Eur. J. Pharmacol. pmid:8566097
Glaser K et al. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. 1995 Eur. J. Pharmacol. pmid:8566109
Altavilla D et al. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis. 1995 Eur. J. Pharmacol. pmid:8566149
Kobayashi I et al. Saiboku-To, a herbal extract mixture, selectively inhibits 5-lipoxygenase activity in leukotriene synthesis in rat basophilic leukemia-1 cells. 1995 J Ethnopharmacol pmid:8569245
Sorem KA and Siler-Khodr TM Placental prostanoid release in severe intrauterine growth retardation. 1995 Placenta pmid:8570572
Nakano T et al. Effects of platelet depletion on PMA-induced acute lung injury in awake sheep. 1995 Respir Physiol pmid:8570923
Umeda F et al. Prostaglandins and diabetic nephropathy. 1995 Oct-Dec J. Diabetes Complicat. pmid:8573760
Lin Y and Sun M [Vasoactive intestinal polypeptide prevents injury of pulmonary vascular permeability due to xanthine with xanthine oxidase]. 1995 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:8575046
Kanamori S et al. Effects of dietary fibre on dimethylhydrazine-induced changes in prostanoid concentrations in rat colonic mucosa. 1995 Clin. Exp. Pharmacol. Physiol. pmid:8575110
Gil B et al. Effects of marine 2-polyprenyl-1,4-hydroquinones on phospholipase A2 activity and some inflammatory responses. 1995 Eur. J. Pharmacol. pmid:8575515
Somova L Effects of iloprost on salt-sensitive Dahl rats. 1995 Methods Find Exp Clin Pharmacol pmid:8577205
Gold MS et al. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8577723
Patrono C et al. Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development. 1995 Thromb. Haemost. pmid:8578493
Cenni E et al. Platelet and coagulation factor variations induced in vitro by polyethylene terephthalate (Dacron) coated with pyrolytic carbon. 1995 Biomaterials pmid:8580259
Lin Y Vasoactive intestinal polypeptide prevents injury of pulmonary vascular permeability due to xanthine with xanthine oxidase. 1995 Chin. Med. Sci. J. pmid:8580482
Lu CS et al. [Experimental study on anti-atherosclerotic effect of tongmai jiangzhi oral liquor]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8580696
Panara MR et al. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. 1995 Br. J. Pharmacol. pmid:8581280
Hsu LY et al. 2-Heteroaryl 2-substituted phenylketone derivatives and their inhibitory activity on platelet aggregation. 1995 J. Pharm. Pharmacol. pmid:8583390
Friedman M et al. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. 1996 J. Thorac. Cardiovasc. Surg. pmid:8583821
Davì G et al. Demonstration of Rickettsia Conorii-induced coagulative and platelet activation in vivo in patients with Mediterranean spotted fever. 1995 Thromb. Haemost. pmid:8584998
Habib A et al. Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies. 1995 Thromb. Haemost. pmid:8585020
Cargile JL et al. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin. 1995 Am. J. Vet. Res. pmid:8585654
Landoni MF et al. Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modelling. 1995 J. Vet. Pharmacol. Ther. pmid:8587147
Kane GC et al. Insights into IgE-mediated lung inflammation derived from a study employing a 5-lipoxygenase inhibitor. 1995 Prostaglandins pmid:8588068
Myers SI et al. Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures. 1995 Prostaglandins pmid:8588069
Jawerbaum A et al. Hyperglycemia promotes elevated generation of TXA2 in isolated rat uteri. 1995 Prostaglandins pmid:8588071
Pettigrew LC et al. Delayed elevation of platelet activating factor in ischemic hippocampus. 1995 Brain Res. pmid:8590061
Pfister SL and Campbell WB Role of endothelium-derived metabolites of arachidonic acid in enhanced pulmonary artery contractions in female rabbits. 1996 Hypertension pmid:8591886
Zhou W et al. Evidence for altered cellular calcium in the pathogenetic mechanism of acute pancreatitis in rats. 1996 J. Surg. Res. pmid:8592406
Yokoyama I et al. Beneficial effect of donor pretreatment with thromboxane A2 synthase inhibitor on the graft survival in pig liver transplantation. 1996 J. Surg. Res. pmid:8592420
Landoni MF and Lees P Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves. 1995 Chirality pmid:8593252
Murray MJ et al. Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. 1995 Am. J. Physiol. pmid:8594921
Berti F et al. Protective effect of furosemide combined with non-steroidal anti-inflammatory drugs administered by inhalation route on guinea-pigs anaphylaxis model. 1995 Arzneimittelforschung pmid:8595068
Jesse RL et al. Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. 1995 Ann. N. Y. Acad. Sci. pmid:8597466
Makheia AN et al. Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic. 1979 Lancet pmid:86023
Sreedhara R et al. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. 1996 Am. J. Kidney Dis. pmid:8604704
Sanderud J et al. D-penicillamine inhibits the action of reactive oxygen species in the pig pulmonary circulation. 1995 J Perinat Med pmid:8606345
Huang JZ et al. Study on characteristics of blast-fragment combined injury in dogs. 1996 J Trauma pmid:8606426
Tarnow P et al. Effects of D-myo-Inositol-1,2,6-triphosphate on eicosanoid formation in burned skin. 1996 J. Surg. Res. pmid:8606494